Posts from — October 2018
Statement: Open Enrollment Begins November 1—Get Covered!
October 31, 2018
We commend Michele Eberle, Executive Director of the Maryland Health Benefit Exchange, for spreading the word that open enrollment in Maryland will go from November 1st to December 15th.... Read more »
Letter to the Editor: The medications don’t work if my patients can’t afford them.
October 30, 2018
As a family physician I write prescriptions every day for medications to help my patients stay healthy — yet more and more of my patients tell me they simply cannot afford their medications.... Read more »
Coalition Announces Senator Kathy Klausmeier as New Lead Senate Sponsor of Prescription Drug Affordability Board Bill
October 26, 2018
The Maryland Health Care For All! Coalition will announce on Monday, October 29 at 11 a.m. that Senator Kathy Klausmeier of Baltimore County will be the new lead Senate Sponsor of the Prescription Drug Affordability Board legislation, joining Delegate Joseline Peña-Melnyk who will once again be the lead House sponsor.... Read more »
Health advocacy group sends supportive mailers in key senate races
October 25, 2018
Maryland Matters October 24, 2018 Danielle Gaines The Maryland Citizens’ Health Initiative is betting that public support for prescription drug affordability could boost the campaigns of three senators facing tough races for reelection. The organization — which has courted pledges of support for a prescription drug affordability board from over 130 candidates for state office […]... Read more »
Statement: Health Advocates Announce Mailers Touting Senators’ Support For Prescription Drug Affordability Initiatives
October 24, 2018
The Maryland Citizens’ Health Initiative announced today it has mounted an aggressive campaign to educate Marylanders about three state senators who have been leaders in the General Assembly in efforts to rein in soaring drug costs. The initiative has paid for mailers to go to voters in the districts of these three senators running for re-election...... Read more »
Frosh takes Maryland’s drug price-gouging statute to the U.S. Supreme Court
October 19, 2018
The Washington Post By Ovetta Wiggins October 19 at 3:27 PM Maryland Attorney General Brian E. Frosh (D) has asked the U.S. Supreme Court to review whether the state’s drug price-gouging statute is constitutional. Frosh said he is asking the court to uphold the 2017 legislation, which has been blocked from taking effect, to bring down the […]... Read more »
LTE: Maryland deserves nothing less
The Frederick News-Post October 19, 2018 Thomas Slater The cost of prescription drugs is skyrocketing out of control, sometimes with terrible consequences for people who depend on those drugs to survive. I hear more and more about people having to choose between basic necessities like food and housing vs. purchasing their prescription drugs. Yet at […]... Read more »
Attorney General Frosh appeals to U.S. Supreme Court to uphold Maryland’s law curbing drug price-gouging
The Baltimore Sun By: Michael Dresser October 19, 2018 Maryland Attorney General Brian Frosh on Friday appealed to the U.S. Supreme Court an earlier decision by a federal court that struck down a Maryland law to curb unreasonable price increases for generic drugs. The General Assembly passed the so-called “price-gouging” law in 2017 at the […]... Read more »
Maryland attorney general asks Supreme Court to uphold generic price gouging law
Stat By: Ed Silverman OCTOBER 19, 2018 The Maryland Attorney General has asked the U.S. Supreme Court to review a decision last spring that a state law enacted to punish generic drug makers for price gouging was unconstitutional. The law permitted the Maryland Medicaid program to notify the state attorney general when an “essential” drug […]... Read more »
Frosh takes generic drug price-gouging appeal to Supreme Court
The Daily Record By: Steve Lash October 19, 2018 Maryland Attorney General Brian E. Frosh on Friday urged the U.S. Supreme Court to revive the state’s law aimed at preventing unwarranted price increases of generic drugs. In papers filed with the justices, Frosh pressed the high court to review and overturn a lower-court decision that struck the […]... Read more »
